M&A wrap: Wynnchurch, Alliance, Leucadia, Jefferies, Stonyrock, Gryphon

The talks follow failed takeover negotiations last year that involved H&R, Blackstone, TPG and Crestpoint Real Estate Investments.

As GP-led secondaries scale to record levels, top investors are flagging a widening gap between trophy assets and weaker deals, even as new financing tools like CFOs further blur the line between sale and securitization.

Riverpoint Medical is a developer and manufacturer of minimally invasive surgical consumables.